HHM Wealth Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.8K Hold
50
﹤0.01% 632
2026
Q1
$11.3K Hold
50
﹤0.01% 623
2025
Q4
$12K Sell
50
-11
-18% -$2.81K ﹤0.01% 590
2025
Q3
$16.7K Hold
61
﹤0.01% 542
2025
Q2
$15.7K Sell
61
-4
-6% -$954 ﹤0.01% 543
2025
Q1
$14.5K Hold
65
﹤0.01% 544
2024
Q4
$14.8K Buy
65
+4
+7% +$963 ﹤0.01% 539
2024
Q3
$14.8K Buy
+61
New +$13.6K ﹤0.01% 508

Other funds holding RMD

HHM Wealth Advisors's RMD Position: Q2 2026 in Review

HHM Wealth Advisors held its ResMed (RMD) position steady in Q2 2026 at 50 shares worth $9.8K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

HHM Wealth Advisors first reported a position in RMD in Q3 2024 and has held it in 8 quarters since. The position peaked at $16.7K in Q3 2025. 222 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • HHM Wealth Advisors held 50 shares of ResMed worth $9.8K as of Q2 2026.
  • HHM Wealth Advisors left its ResMed share count unchanged in Q2 2026.
  • ResMed made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #632 holding.
  • HHM Wealth Advisors first reported a position in ResMed in Q3 2024 and has held it in 8 quarters since.
  • HHM Wealth Advisors's ResMed position peaked at $16.7K in Q3 2025.
  • 222 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.